Ropharma Bras Cash Flow Conversion Efficiency
Ropharma Bras cash flow conversion efficiency. Based on the latest financial reports, Ropharma Bras (RPH) has a cash flow conversion efficiency ratio of 0.075x as of March 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RON14.80 Million ≈ $3.40 Million USD) by net assets (RON197.59 Million ≈ $45.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ropharma Bras (2021–2025)
Cash flow conversion efficiency of Ropharma Bras from 2021 to 2025. This chart illustrates how Ropharma Bras's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Ropharma Bras for real-time trading data and today's change.
Ropharma Bras Cash Flow Conversion Ratio Explained
Ropharma Bras cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ropharma Bras Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ropharma Bras ranked by their cash flow conversion efficiency. Also see RPH company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bhagyanagar India Limited
NSE:BHAGYANGR
|
-0.339x |
|
Centric Holdings S.A
AT:CENTR
|
0.008x |
|
Artea SA
PA:ARTE
|
-0.078x |
|
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
|
-0.151x |
|
Qleanair Holding AB
ST:QAIR
|
0.114x |
|
Varengold Bank AG
F:VG8
|
N/A |
|
Lyka Labs Limited
NSE:LYKALABS
|
0.135x |
|
Apex Equity Holdings Bhd
KLSE:5088
|
0.143x |
Annual Cash Flow Conversion Efficiency for Ropharma Bras (2021–2025)
The table below shows the annual cash flow conversion efficiency of Ropharma Bras from 2021 to 2025. Review cash generation quality of Ropharma Bras to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | RON259.34 Million ≈ $59.55 Million |
RON43.16 Million ≈ $9.91 Million |
0.166x | +3.52% |
| 2024-06-30 | RON251.85 Million ≈ $57.83 Million |
RON40.49 Million ≈ $9.30 Million |
0.161x | +25.38% |
| 2023-06-30 | RON233.49 Million ≈ $53.61 Million |
RON29.94 Million ≈ $6.87 Million |
0.128x | +61.79% |
| 2022-06-30 | RON184.92 Million ≈ $42.46 Million |
RON14.65 Million ≈ $3.36 Million |
0.079x | +260.42% |
| 2021-06-30 | RON174.90 Million ≈ $40.16 Million |
RON-8.64 Million ≈ $-1.98 Million |
-0.049x | -- |
About Ropharma Bras
S.C. Ropharma S.A., together with its subsidiaries, operates a chain of pharmacies in Romania. The company offers medicines on prescription, over-the-counter (OTC) medications, food supplements, dermato-cosmetics, cosmetics, and medical devices, as well as other healthcare products dispensed through pharmacies. It also provides medical services in various areas, including oncology, hematology, on… Read more